Dynasore: Noncompetitive Dynamin GTPase Inhibitor for Endocytosis Research

Executive Summary: Dynasore (SKU A1605, APExBIO) is a cell-permeable, noncompetitive inhibitor of dynamin GTPase activity with an IC₅₀ of 15 µM, validated in multiple eukaryotic models and across cell types (APExBIO). It selectively inhibits dynamin1, dynamin2, and Drp1, blocking dynamin-dependent endocytosis in a reversible fashion (Wang et al., 2018). Dynasore’s mechanism provides precise control over clathrin-mediated endocytosis, as demonstrated in HL-1 cells and neurons. Its chemical properties require DMSO for solubilization (≥16.12 mg/mL), with optimal storage at -20°C. Dynasore’s specificity, reversibility, and broad utility render it indispensable for mechanistic studies in vesicle trafficking, signal transduction, and disease modeling.

Biological Rationale

Dynamin GTPases are essential for membrane scission during endocytosis and vesicle trafficking. Dynamin1, dynamin2, and Drp1 are involved in signal transduction, protein biosynthesis, membrane protein translocation, and vesicle-mediated transport. Dysregulation of dynamin-dependent pathways is implicated in neurodegenerative diseases, cancer, and viral infection models (Wang et al., 2018). Targeting these GTPase-mediated pathways enables mechanistic dissection of endocytosis and synaptic vesicle recycling, as well as the study of host-pathogen interactions. Pharmacological inhibition with agents such as Dynasore allows precise temporal and reversible blockade of these critical cellular events.

Mechanism of Action of Dynasore

Dynasore is a reversible, noncompetitive inhibitor of dynamin GTPase activity. It binds dynamin1, dynamin2, and Drp1, preventing GTP binding and hydrolysis without competing at the GTP-binding site (APExBIO). This results in acute inhibition of dynamin-dependent endocytosis, particularly clathrin-mediated pathways. The effect is rapid-onset and reversible upon compound removal. Dynasore blocks transferrin uptake and synaptic vesicle endocytosis in neurons and HL-1 cells. Its selectivity for dynamin over other GTPases enables dissection of endocytic pathways with high precision (GTP Solution). Dynasore’s action has been benchmarked in mechanistic studies across cell types and experimental systems.

Evidence & Benchmarks

• Dynasore (15 µM) inhibits dynamin-dependent endocytosis and blocks viral entry in CIK cells infected with grass carp reovirus type III (GCRV104), as measured by reduced viral titers and suppressed cytopathic effect (Wang et al., 2018, Table 2, 24h post-infection).
• Transferrin uptake is reversibly inhibited by Dynasore in HL-1 cells under standard cell culture conditions (37°C, DMSO vehicle, 15–80 µM), with effects observed within minutes (APExBIO product documentation).
• Synaptic vesicle endocytosis in neurons is blocked acutely by Dynasore at concentrations of 15–80 µM; removal restores endocytic function within 10–30 minutes (Transferrin Fragment).
• Dynasore is insoluble in water and ethanol but achieves solubility in DMSO at concentrations ≥16.12 mg/mL, facilitating preparation of concentrated stock solutions for cell-based assays (APExBIO).
• Dynasore does not inhibit dynamin-independent endocytosis (e.g., caveolin-mediated) or significantly affect unrelated GTPases at standard working concentrations (Dynamin Inhibitory Peptide).

Applications, Limits & Misconceptions

Dynasore is widely used to interrogate endocytosis, vesicle trafficking, and dynamin GTPase signaling pathways in cell biology, neurobiology, and cancer research. It enables mechanistic studies of host-pathogen interactions, such as viral entry via clathrin-mediated endocytosis (Wang et al., 2018). Dynasore is also utilized in neurodegenerative disease models to dissect synaptic vesicle cycling and neurotransmission. Its reversibility and specificity make it highly suitable for time-resolved experiments.

Compared to other dynamin inhibitors, Dynasore (from APExBIO) offers a noncompetitive mechanism, rapid washout, and robust performance in diverse cellular models. For advanced troubleshooting and translational innovation, see this article, which details optimizations and workflow strategies; this current dossier further clarifies Dynasore’s validated use in viral entry studies and mechanistic benchmarks.

Common Pitfalls or Misconceptions

• Dynasore does not inhibit caveolin-mediated or macropinocytosis pathways at standard concentrations; effects are specific to dynamin-dependent endocytosis (Wang et al., 2018).
• It is not suitable for water-based or ethanol-based stock solutions due to insolubility; use DMSO exclusively for stock preparation (APExBIO).
• Dynasore is not intended for in vivo diagnostic or therapeutic use; it is for research applications only.
• Cell toxicity may occur at concentrations >80 µM or with prolonged exposure; optimize dosing and exposure time for each cell type (Dynamin Inhibitory Peptide).
• Some studies report off-target effects at very high concentrations; titrate carefully and use matched controls.

Workflow Integration & Parameters

For optimal use, prepare Dynasore stock solutions in DMSO at concentrations ≥16.12 mg/mL. Warm to 37°C or sonicate to increase solubility. Store aliquots at -20°C for several months. Typical working concentrations range from 10–80 µM in cell culture, with acute exposure (minutes to hours) for reversible inhibition. Always include DMSO vehicle controls and titrate concentration to minimize cytotoxicity. Removal of Dynasore restores dynamin activity within 10–30 minutes in most models. For troubleshooting and advanced protocols, refer to this resource, which APExBIO's current documentation updates with new evidence from viral entry and synaptic studies.

Conclusion & Outlook

Dynasore is a robust, validated tool for dissecting dynamin-dependent endocytosis and vesicle trafficking. Its noncompetitive, reversible inhibition profile enables precise control in cell-based assays, from fundamental mechanistic studies to advanced disease models. With strong evidence for specificity and utility, Dynasore (SKU A1605, APExBIO) remains indispensable for research on signal transduction, neurodegeneration, cancer, and host-pathogen interactions. This dossier extends prior workflow guides (see more scenario-driven Q&A here) by anchoring Dynasore’s role in viral entry inhibition and clarifying practical integration for experimental reliability.